FDA recall D-0183-2023

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon · Class I · drug

Product

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

Reason for recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Distribution

Nationwide in the USA.

Key facts

Status: Terminated
Initiation date: 2022-12-06
Report date: 2023-02-01
Termination date: 2024-02-26
Voluntary/Mandated: Voluntary: Firm initiated
Location: Warren, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0183-2023